SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending following its decision to pull a newly launched compounded weight-loss pill due to regulatory pressure and legal threats. This move has sparked debate, with some viewing it as a significant setback while others believe it strategically removes a legal overhang and positions the core telehealth platform for a rebound, amplified by its Super Bowl ad.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as record Super Bowl betting drives immense volume and its Crypto.com partnership expands prediction markets, while the community actively debates whether emerging unregulated prediction platforms pose a significant threat ahead of next week's anticipated earnings.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after announcing a $250 million financing amendment, extending its capital runway through 2028, which bulls anticipate will fuel a historic short squeeze given its low float and past parabolic runs. However, community discussion also highlights concerns about potential dilution from the equity line of credit amidst the company's current lack of revenue generation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending following a significant Super Bowl commercial featuring Christina Applegate for its Briumvi multiple sclerosis drug, which the community views as a powerful boost for brand visibility and patient confidence. This marketing success, combined with growing discussion over a competitor's drug (Fenebrutinib) and its potential liver toxicity concerns, is intensifying conversation around Briumvi's market leadership and long-term value.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

$JYAI is trending due to recent exchange listings on platforms like Bitget and KuCoin Alpha, an active 12-week marketing campaign, and community excitement around 'JerryVerse' content potentially coming to Netflix, fueling discussions that it could be the next major meme coin like $PEPE.

WorldFinancial

WLFI is trending due to a congressional probe into a significant foreign investment and its pursuit of a US banking license for its USD1 stablecoin, sparking intense community debate. Investors are polarized between those who view it as a politically-linked "scam" and others who see long-term potential in its Real-World Asset (RWA) tokenization and "future of finance" aspirations.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is experiencing a strong rally fueled by a resurgence in M&A activity, highlighted by recent acquisitions and numerous buyout rumors as major pharmaceutical companies actively seek to replenish pipelines ahead of patent cliffs. The community is buzzing about a "BioWar" and the sector's perceived undervaluation, with optimism further boosted by positive individual drug developments.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as strong institutional accumulation and anticipation of a potential Chronoscale spinoff fuel bullish sentiment, with the community highlighting the company's growing contracted revenue pipeline and strategic position to capitalize on massive hyperscaler capital expenditures for AI infrastructure, despite recent market volatility.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending with significant anticipation for its upcoming earnings, as the community sharply debates the impact of a proposed credit card interest rate cap on its AI-powered lending model and the broader fintech sector's outlook. This division reflects ongoing concerns about management's execution against a backdrop of macroeconomic uncertainty.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending following its acquisition of Astria Therapeutics, adding a late-stage HAE drug and other assets, but the community is vocal about the significant share dilution and perceived short manipulation that keeps the stock undervalued despite its growing revenue and improving financials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Penserra Capital Management LLC Buys Shares of 80,556 Travere Therapeutics, Inc. $TVTX

Penserra Capital Management LLC bought a new stake in Travere Therapeutics, Inc. (NASDAQ:TVTX - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and...

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CFO Sells $56,171.55 in Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) CFO Christopher Cline sold 1,745 shares of Travere Therapeutics stock in a transaction that occurred on Wednesday, February 4th. The stock...

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CFO Sells 1,745 Shares of Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) CFO Christopher Cline sold 1,745 shares of the stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an...

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $57,301.59 in Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) insider Jula Inrig sold 1,779 shares of the firm's stock in a transaction dated Wednesday, February 4th. The shares were sold at an average...

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) Insider Sells 2,994 Shares of Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) insider Elizabeth Reed sold 2,994 shares of the company's stock in a transaction that occurred on Wednesday, February 4th. The stock was...

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CFO Sells 7,242 Shares of Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) CFO Christopher Cline sold 7,242 shares of the company's stock in a transaction on Tuesday, February 3rd. The shares were sold at an average...

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $234,797.20 in Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) insider Peter Heerma sold 7,310 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold...

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $230,461.00 in Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) insider Elizabeth Reed sold 7,175 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an...

William Rote Sells 12,446 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) insider William Rote sold 12,446 shares of Travere Therapeutics stock in a transaction on Tuesday, February 3rd. The shares were sold at an...

Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube Sells 100,087 Shares

Travere Therapeutics, Inc. (NASDAQ:TVTX - Get Free Report) CEO Eric Dube sold 100,087 shares of the company's stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price...

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

TVTX
Travere Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TVTX News

TVTXTravere Therapeutics Inc